Excipient Market Overview: Roquette announces restructuring post IFF Pharma buyout; WHO, FDA advance regulatory frameworks

Data Compilation
#PharmaFlow

Pipeline Prospector May 2025: Pfizer strikes US$ 6 bn oncology pact; Lilly diversifies pipeline with US$ 2.3 bn in deals

Stock Recap
#PipelineProspector

Novo-ondansetron

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

31 API Suppliers, 8 USDMF, 10 EU WC, 3 KDMF, 10 NDC API, 21 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

41 Drugs in Development

41 Drugs in Development

INTERMEDIATES

13 Intermediate Suppliers

13 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

458 FDF Dossiers, 29 FDA Orange Book, 143 Europe, 24 Canada, 103 Australia, 51 South Africa, 108 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, ORALLY DISINTEGRATING;ORAL - 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - 8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FILM;ORAL - 4MG, FILM;ORAL - 8MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 6 Rochem International Inc, 23 SPI Pharma, 12 DKSH, 2 Pharm-RX Chemical, 6 Faran Shimi Pharmaceutical, 4 Boai NKY Pharmaceuticals Ltd, 9 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 2 Shanghai Minbiotech, 1 Pfanstiehl, 4 ACG Worldwide, 9 Actylis, 2 Aeon Procare, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 17 BASF, 1 Bioplus Life Sciences, 11 Corel Pharma Chem, 7 DFE Pharma, 1 Doshion Polyscience, 1 Finar, 11 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 37 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 16 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 2 Novo Excipients, 4 Pharmatrans-Sanaq, 6 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 29 Roquette, 13 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 5 Silverline Chemicals, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 5 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

85 Fillers, Diluents & Binders, 46 Coating Systems & Additives, 46 Disintegrants & Superdisintegrants, 39 Direct Compression, 31 Thickeners and Stabilizers, 27 Taste Masking, 26 Controlled & Modified Release, 25 Granulation, 23 Chewable & Orodispersible Aids, 22 Lubricants & Glidants, 21 Co-Processed Excipients, 20 Solubilizers, 18 Film Formers & Plasticizers, 14 Parenteral, 12 Topical, 9 Empty Capsules, 8 Rheology Modifiers, 7 API Stability Enhancers, 7 Emulsifying Agents, 4 Vegetarian Capsules, 4 Coloring Agents, 2 Surfactant & Foaming Agents, 1 Soft Gelatin

DIGITAL CONTENT

31 News #PharmaBuzz

31 News #PharmaBuzz

GLOBAL SALES INFORMATION

130 Regulatory FDF Prices

130 Regulatory FDF Prices

MARKET PLACE

14 APIs, 23 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 US Patents, 2 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 Others

4 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Name of the Firm	Written Confirmation No.	Product Name	Issue Date	Valid Till	Address of the Firm
04/06/2025	Dr. Reddy's Laboratories	India	M/s Dr. Reddys Laboratories Ltd	WC-0043	Ondansetron USP/IH	2022-05-27	2025-06-04	Chemical Technical Operations ? Unit V, Peddadevulapally Village, Tripuraram Mandal, Nalgonda District, Telangana
04/06/2025	Cipla	India	M/s CIpla Limited	WC-0144nA2	Ondansetron IH	2022-06-08	2025-09-08	D-7, MIDC, Industrial Area, Kurkumbh, Taluka: Daund, District: Pune -Zone4- 413802, Maharashtra, India

Novo-ondansetron

Novo-ondansetron

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

31 API Suppliers

8 USDMF

10 EU WC

3 KDMF

10 NDC API

21 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

41 Drugs in Development

INTERMEDIATES

13 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

458 FDF Dossiers

29 FDA Orange Book

143 Europe

24 Canada

103 Australia

51 South Africa

108 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, ORALLY DISINTEGRATING;ORAL - 4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, ORALLY DISINTEGRATING;ORAL - 8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

FILM;ORAL - 4MG

FILM;ORAL - 8MG

RELATED EXCIPIENT COMPANIES

1 Minakem

6 Rochem International Inc

23 SPI Pharma

12 DKSH

2 Pharm-RX Chemical

6 Faran Shimi Pharmaceutical

4 Boai NKY Pharmaceuticals Ltd

9 Gangwal Healthcare

3 Nanjing Well Pharmaceutical

2 Shanghai Minbiotech

1 Pfanstiehl

4 ACG Worldwide

9 Actylis

2 Aeon Procare

1 Alcedo Pharmachem

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

17 BASF

1 Bioplus Life Sciences

11 Corel Pharma Chem

7 DFE Pharma

1 Doshion Polyscience

1 Finar

11 Gangwal Chemicals

5 Ideal Cures Pvt Ltd

5 Ingredion Pharma Solutions

37 Kerry

3 Kima Chemical

6 Lonza Capsugel

16 Microlex e.U

1 Nanjing Bold Chemical

2 Nomisma Healthcare

2 Novo Excipients

4 Pharmatrans-Sanaq

6 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

29 Roquette

13 Seppic

8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

2 Shijiazhuang Huaxu Pharmaceutical

11 Sigachi Industries

5 Silverline Chemicals

2 The Dow Chemical Company

1 Ulanqab Kema New Material

1 Valens Pharmachem

5 Vasa Pharmachem

TABLET, ORALLY DISINTEGRATING;ORAL - 4MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, ORALLY DISINTEGRATING;ORAL - 8MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons